Pulmonx Corp is a commercial-stage medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LUNG is expected to report earnings to rise 11.58% to -40 cents per share on July 30
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.81
Q2'24
Beat
by $0.03
The last earnings report on April 30 showed earnings per share of -36 cents, beating the estimate of -38 cents. With 357.06K shares outstanding, the current market capitalization sits at 357.24M.